Tuesday, December 1, 2009

Sun Pharma recieves FDA approval for Nicardipine injection

Sun Pharma and its subsidiary has been granted approval for its application for Nicardipine Hydrochloride Injections by the USFDA. These Nicardipine Hydrochloride Injections are available as 25 mg/10ml single use ampuls containing 2.5 mg/ml of the drug, and have annual sales of approximately USD 170 million in the US. These injections are used for the short-term treatment of hypertension when oral therapy is not feasible or not desirable.

No comments: